Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last A$0.09 AUD
Change Today +0.005 / 6.02%
Volume 2.6M
NEU On Other Exchanges
Symbol
Exchange
OTC US
As of 1:42 AM 07/3/15 All times are local (Market data is delayed by at least 15 minutes).

Earnings & Estimates Summary - NEUREN PHARMACEUTICALS LTD (NEU)

Neuren Pharmaceuticals Limited to Report Q4, 2014 on Feb 25, 2015
CapIQ 02/25/2015 5:00 AM ET

2013 revenues at Neuren Pharmaceuticals Limited totaled 5.2M, while annual losses equaled $0.01 per share.

Quarterly Earnings & Estimates - NEUREN PHARMACEUTICALS LTD (NEU)

Actuals vs. Estimates for NEUREN PHARMACEUTICALS LTD NEU

No earnings announcements are currently available for NEUREN PHARMACEUTICALS LTD.

Annual Earnings & Estimates - NEUREN PHARMACEUTICALS LTD (NEU)

Chart not available

Neuren Pharmaceuticals Limited's Annual Earnings

Neuren Pharmaceuticals Limited reported annual 2013 losses of A$0.01 per share on 02/28/2014.

Quarterly Revenues - NEUREN PHARMACEUTICALS LTD (NEU)

Actuals vs. Estimates for NEUREN PHARMACEUTICALS LTD NEU

Annual Revenues - NEUREN PHARMACEUTICALS LTD (NEU)

Chart not available
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
NEU:AU A$0.09 AUD +0.005

NEU Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for NEU.
View Industry Companies
 

Industry Analysis

NEU

Industry Average

Valuation NEU Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 43.1x
Price/Book 6.8x
Price/Cash Flow NM Not Meaningful
TEV/Sales 38.2x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact NEUREN PHARMACEUTICALS LTD, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.